China's mRNA Vaccine Market Remains in Infancy
China's mRNA Vaccine Market Remains in Infancy
Attachment: China vaccines 0721
BEIJING--July 27, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Only 15 types of messenger RNA (mRNA) vaccines are being researched worldwide. Three of the companies involved--CuerVac, Moderna and BioNTech--are considered giants within the market. Although eight of China's pharmaceutical companies are concentrating on mRNA vaccines, all remain in the beginning stages. No licensed mRNA vaccine is yet on Chinese market.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects